Effect of rapamycin on the expression of the IL-2 receptor (CD25)

Clinical and Experimental Immunology

Volumn 103, Issue 2, 1996, Pages 322-327

  Woerly, G ^a   Brooks, N ^a   Ryffel, B ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

CD25; FK506; IL 2 receptor; Rapamycin; T lymphocyte activation

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030064475     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-616.x     Document Type: Article

References (29)

1. Waldmann TA. The interleukin-2 receptor. J Biol Chem 1988; 266:2681-5.
2. Hatakeyama M, Tsudo M, Minamoto S et al. Interleukin-2 receptor β chain gene: generation of three receptor forms by cloned human α and β chain cDNA's. Science 1989; 244:551-4.
3. Takeshita T, Asao H, Ohtani K et al. Cloning of the γ chain of the human IL-2 receptor. Science 1992; 257:379-84.
4. Smith KA, Cantrell D. Interleukin 2 regulates its own receptors. Proc Natl Acad Sci USA 1984; 82:864-9.
5. Minami Y, Kono T, Miyazaki T, Taniguchi T. The IL-2 receptor complex: its structure, function and target genes. Annu Rev Immunol 1993; 11:245-73.
6. Minami Y, Taniguchi T. The IL-2 receptor system: a current overview. Cell 1992; 73:5-9.
7. Krönke M, Leonard WJ, Depper JM et al. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 1984; 81:5214-8.
8. Borel JF. Pharmacology of cyclosporine. Pharmacol Rev 1989; 41:239-312.
9. Sigal N, Dumont FJ. Cyclosporin A, FK-506 and rapamycin: pharmacological probes of lymphocyte signal transduction. Ann Rev Immunol 1992; 10:519-62.
10. Foxwell B, Simon J, Herrero J, Taylor D, Woerly G, Cantrell D, Ryffel B. Anti-CD3 antibody-induced expression of both p55 and p75 chains of the high affinity interleukin-2 receptor on human T lymphocytes is inhibited by cyclosporin A. Immunology 1990; 69:104-14.
11. Depper JM, Leonard WJ, Drogula C, Krönke M. Waldmann TA, Greene WC. Interleukin 2 augments transcription of the IL-2 receptor gene. Proc Natl Acad Sci USA 1985; 83:4230-3.
12. Harel-Bellan A, Bertoglio J, Quillet A, Marchiol J, Wakasugi H, Mishall Z. Fradelizi D. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation. J Immunol 1986; 136:2463-9.
13. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991; 66:807-15.
14. Schreiber S, Crabtree G. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992; 13:136-40.
15. Bierer B, Mattila P, Standaert R, Herzenberg L, Burakoff ST, Crabtree G, Schreiber ST. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc Natl Acad Sci USA 1990; 87:9231-5.
16. Dumont FJ, Staruch MJ, Koprak S, Melino MM, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK506 and rapamycin. J Immunol 1990; 144:251-9.
17. Chung J, Kuo CJ, Crabtree GR, Blenis J. Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kD S6 protein kinases. Cell 1992; 69:1227-33.
18. Kip1 cyclin-dpendcnt kinase inhibitor prevented by rapamycin. Nature 1994; 372:570-3.
19. Brown E, Albers M, Shin T, Ichikawa K, Keith C, Lane W, Schreiber S. A mammalian protein targeted by G1-arresting rapamycin receptor complex. Nature 1994; 369:756-8.
20. Sabatini D, Erdjument-Bromage H, Lui M, Tempst P, Snyder S. RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependcnt fashion and is homologous to yeast TORs. Cell 1994; 78:35-43.
21. 1 progression. Cell 1993; 73:585-96.
22. Taylor-Fishwick DA, Kahan M, Hiestand P, Ritter MA, Foxwell BM. Evidence that rapamycin has differential effects of IL-4 function. Multiple IL-4 signalling pathways and implications for in vivo use. Transplantation 1993; 46:468-74.
23. Laemmli UK. Cleavage of structural proteins during the assembly to the head of bacteriophage T 4. Nature 1970; 227:680-3.
24. Gauchat JF, Khandjian EW, Weil R. Cyclosporin A prevents induction of the interleukin 2 receptor gene in cultured murine thymocytes. Proc Natl Acad Sci USA 1986; 83:6430-5.
25. Foxwell B, Taylor D, Greiner B, Mihatsch MJ, Olivieri V, Ryffel B. Biotinylated recombinant interleukin-2. J Immunol Methods 1988; 113:221-7.
26. Henderson D, Naya I, Bundick R, Smith G, Schmidt A. Comparison of the effects of FK-506, cyclosporin A and rapamycin on IL-2 production. Immunology 1991; 73:316-22.
27. Kay J, Kromwel L, Doe S, Denyer M. Inhibition of T and B lymyphocyte proliferation by rapamycin. Immunology 1991; 72:544-9.
28. Lin S, Boltz R, Siekierka J, Sigal N. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T-lymphocytes. Cell Immunol 1991; 133:269-75.
29. Wicker L, Boltz RC, Matt V, Nichols E, Peterson L, Sigal N. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. Eur J Immunol 1990; 20:2277-84.